15110 DALLAS PKWY, SUITE 600, DALLAS, TX
Termination of Business Combination Agreement with Nuclea Energy Inc.
Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination
Ex-99.1
Mangoceuticals, Inc. Enters Subscription Agreement for $272,000
Reg. FD
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy
Q2
Q1
FY 2025
Notice of Late Filing for Annual Report
Amended Quarterly Report
Q3
Prospectus Filed Pursuant to Rule 425
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload